Table 3 Comorbidities and factors associated with death at hospital - Univariate logistic analysis

CNS infection

6

42.3

23

46.0

0.88

0.27-2.91

Monotherapy (n = 57)

7

77.8

27

56.3

2.72

0.51-14.49

Male

9

64.3

25

50.0

1.80

0.53-6.13

Saint Luc hospital

12

86.0

40

80.0

1.50

0.29-7.81

Diabetes mellitus

2

14.3

6

12.0

1.22

0.22-6.85

Immunosuppressive therapy

8

57.1

26

52.0

1.23

0.37-1.07

Cancer

7

50.0

15

30.0

2.33

0.70-7.82

Alcoholism

0

0.0

3

6.0

/

/

Renal disease

7

50.0

10

20.0

4.00

1.14-14.48**

HIV infection

1

7.1

5

10.0

0.69

0.07-6.46

Transplantation

5

35.7

7

14.0

3.41

0.88-13.22

Severe cardiovascular disease

8

57.1

11

22.0

4.73

1.35-16.54**

Hepatic disease

5

35.7

6

12.0

4.07

1.02-16.30**

Auto-immune disease

0

0.0

5

10.0

/

/

Immunocompromised status

11

78.6

30

60.0

2.44

0.61-9.88

Mean

SD

Mean

SD

OR

95 % CI

Age in years at admission

67.9

9.9

56.8

20.5

1.04

0.98-1.09

BMI (n = 33)

25.4

3.0

24.0

5.8

1.05

0.90-1.23

Systole at admission (mmHg) (n = 55)

116.7

20.6

127.5

32.8

0.99

0.97-1.01

Diastole at admission (mmHg)

68.7

10.5

73.3

17.5

0.98

0.94-1.03

% neutrophil in blood at admission (n = 41)

69.7

30.8

75.1

18.9

0.99

0.96-1.02

% lymphocytes in blood at admission (n = 37)

11.7

9.5

15.2

13.7

0.97

0.89-1.06

CRP mg/dl at admission (n = 47)

55.1

110.5

28.1

32.3

1.01

0.96-1.02

Creatinine in blood at admission mg/L (n = 60)

7.1

15.5

3.0

3.6

1.06

0.97-1.16

Blood platelets at admission/L (10³) (n = 56)

170.7

86.3

248.9

314.5

0.98

0.99-1.01

% neutrophil in CSF (n = 20)

83.8

11.5

67.4

23.8

1.06

0.94-1.19

Median

Range

Median

Range

OR

95 % CI

Admission year

2004

1984-2013

2003

1978-2014

1.01

0.95-1.07